Video

Global, Industry-Leading Decentralized Clinical Research Offering

Source: United BioSource LLC (UBC)

UBC utilizes THREAD, a technology and service provider enabling DCTs, to leverage decentralized approaches across studies in the UBC portfolio. The fully connected offering further enables powerful decentralized approaches, rapid program start-up timelines, and a more integrated offering from data acquisition through actionable insights in a single platform.

UBC’s market-leading virtual evidence generation offering is enhanced by THREAD’s platform and services, which enable organizations to conduct DCTs globally with established tools that include eConsent, eCOA, sensors, devices, telehealth, and engaging patients that participate in UBC programs. UBC’s existing offering includes digital recruitment and engagement strategies, in-home nursing support, clinical assessments, and drug administration, as well as powerful real-world data infrastructure, data enrichment strategies, and rapid analytics software to accelerate more informed decision making.

This video explains how a fully integrated solution is driving the trend towards decentralized clinical trial (DCT) designs and tactics to support phase II-IV clinical trials, pragmatic studies, and late-stage observational research. 

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader